Clearside Biomedical, Inc. (CLSD)
NASDAQ
Market Cap
$90.42M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
133 of 809
Rank in Industry
88 of 445
Largest Insider Buys in Sector
CLSD Stock Price History Chart
CLSD Stock Performance
About Clearside Biomedical, Inc.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Insider Activity of Clearside Biomedical, Inc.
Over the last 12 months, insiders at Clearside Biomedical, Inc. have bought $929,858 and sold $39,372 worth of Clearside Biomedical, Inc. stock.
On average, over the past 5 years, insiders at Clearside Biomedical, Inc. have bought $608,369 and sold $697,766 worth of stock each year.
Highest buying activity among insiders over the last 12 months: WHITMORE BRADFORD T (10 percent owner) — $1.4M. Gibney Anthony S (director) — $129,665. Chong Ngai Hang Victor (CHIEF MEDICAL OFFICER) — $72,910.
The last purchase of 23,500 shares for transaction amount of $24,910 was made by Chong Ngai Hang Victor (Chief Medical Officer) on 2024‑06‑24.
List of Insider Buy and Sell Transactions, Clearside Biomedical, Inc.
| 2024-06-24 | Chong Ngai Hang Victor | Chief Medical Officer | 23,500 0.0309% | $1.06 | $24,910 | +15.74% | ||
| 2024-05-15 | YERXA BENJAMIN R | director | 7,813 0.0104% | $1.31 | $10,235 | -5.30% | ||
| 2024-04-18 | Gibney Anthony S | director | 93,290 0.123% | $1.30 | $121,277 | -3.38% | ||
| 2024-04-17 | Gibney Anthony S | director | 6,710 0.0089% | $1.25 | $8,388 | +3.20% | ||
| 2024-03-20 | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | 30,000 0.0394% | $1.60 | $48,000 | -20.55% | ||
| 2024-02-07 | WHITMORE BRADFORD T | 10 percent owner | 444,444 0.7241% | $1.35 | $599,999 | -3.62% | ||
| 2024-01-19 | Sale | LASEZKAY GEORGE M | CEO | 18,000 0.0286% | $1.27 | $22,860 | +3.52% | |
| 2024-01-19 | Sale | Deignan Charles A. | Chief Financial Officer | 12,900 0.0207% | $1.28 | $16,512 | +3.52% | |
| 2023-11-01 | WHITMORE BRADFORD T | 10 percent owner | 64,366 0.101% | $0.74 | $47,901 | +69.07% | ||
| 2023-10-31 | WHITMORE BRADFORD T | 10 percent owner | 70,812 0.1147% | $0.73 | $51,537 | +77.34% | ||
| 2023-10-30 | WHITMORE BRADFORD T | 10 percent owner | 600 0.001% | $0.69 | $411 | +85.78% | ||
| 2023-10-03 | Hutson Nancy J | director | 10,000 0.0159% | $0.86 | $8,600 | +47.82% | ||
| 2023-09-25 | Thorp Clay | director | 10,000 0.0163% | $0.86 | $8,600 | +47.06% | ||
| 2023-01-20 | Sale | Ciulla Thomas | Chief Medical Officer | 13,700 0.0223% | $1.47 | $20,139 | -28.67% | |
| 2023-01-19 | Sale | LASEZKAY GEORGE M | CEO | 20,030 0.033% | $1.46 | $29,244 | -27.21% | |
| 2023-01-19 | Sale | Deignan Charles A. | Chief Financial Officer | 14,030 0.0238% | $1.50 | $21,045 | -27.21% | |
| 2023-01-10 | Sale | Ciulla Thomas | Chief Medical Officer | 2,170 0.0035% | $1.62 | $3,515 | -35.54% | |
| 2022-12-21 | Thorp Clay | director | 14,000 0.0236% | $1.02 | $14,266 | +7.00% | ||
| 2022-11-17 | Hutson Nancy J | director | 30,000 0.0489% | $1.33 | $39,900 | -18.52% | ||
| 2022-01-19 | Sale | LASEZKAY GEORGE M | CEO | 10,800 0.0181% | $2.12 | $22,896 | -30.33% |
Insider Historical Profitability
26.36%
| WHITMORE BRADFORD T | 10 percent owner | 4495034 7.2026% | $1.21 | 11 | 3 | +79.94% |
| LASEZKAY GEORGE M | CEO | 466577 0.7476% | $1.21 | 1 | 11 | +58.62% |
| Deignan Charles A. | Chief Financial Officer | 384662 0.6164% | $1.21 | 4 | 7 | +20.35% |
| Hutson Nancy J | director | 93000 0.149% | $1.21 | 5 | 0 | <0.0001% |
| Gibney Anthony S | director | 100000 0.1338% | $1.21 | 2 | 0 | |
| Thorp Clay | director | 40522 0.0649% | $1.21 | 4 | 41 | +1.04% |
| Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | 63500 0.0401% | $1.21 | 2 | 0 | |
| YERXA BENJAMIN R | director | 17957 0.024% | $1.21 | 1 | 0 | |
| Hatteras Venture Advisors IV SBIC, LLC | 10 percent owner | 2060514 3.3016% | $1.21 | 1 | 4 | +13.15% |
| Hatteras Venture Advisors III, LLC | 10 percent owner | 1757719 2.8165% | $1.21 | 1 | 4 | +13.15% |
| RMI Investments S.a.r.l. | 10 percent owner | 1558024 2.4965% | $1.21 | 1 | 0 | +13.15% |
| White Daniel H. | President and CEO | 483335 0.7745% | $1.21 | 1 | 13 | |
| Ciulla Thomas | Chief Medical Officer | 291890 0.4677% | $1.21 | 0 | 4 | |
| Cagle Gerald D. | director | 23441 0.0376% | $1.21 | 4 | 1 | +5.28% |
| Humphries William D. | director | 5586 0.009% | $1.21 | 1 | 0 | +50% |
| SHAFFER CHRISTY L | director | 4400 0.0071% | $1.21 | 3 | 0 | +7.86% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Armistice Capital Llc | $6.05M | 5.29 | 3.96M | New | +$6.05M | 0.07 | |
| The Vanguard Group | $3.81M | 3.33 | 2.49M | +14.45% | +$481,154.41 | <0.0001 | |
| Carmignac | $3.26M | 2.85 | 2.13M | 0% | +$0 | 0.05 | |
| BlackRock | $1.16M | 1.02 | 758,226 | -0.2% | -$2,321.01 | <0.0001 | |
| Geode Capital Management | $982,799.00 | 0.86 | 642,213 | +30.88% | +$231,880.47 | <0.0001 | |
| Renaissance Technologies | $837,000.00 | 0.73 | 546,789 | +42.14% | +$248,135.39 | <0.01 | |
| Millennium Management LLC | $316,598.00 | 0.28 | 206,927 | +515.16% | +$265,131.91 | <0.0001 | |
| State Street | $295,845.00 | 0.26 | 193,363 | 0% | +$0 | <0.0001 | |
| Jane Street Capital | $270,360.00 | 0.24 | 176,706 | New | +$270,360.00 | <0.0001 | |
| First Manhattan Co. | $267,750.00 | 0.23 | 175,000 | 0% | +$0 | <0.01 | |
| Johnson & Johnson | $259,532.00 | 0.23 | 169,629 | 0% | +$0 | 0.01 | |
| Castleview Partners LLC | $247,802.00 | 0.22 | 161,962 | New | +$247,802.00 | 0.17 | |
| Morgan Stanley | $234,158.00 | 0.21 | 153,044 | +5.96% | +$13,173.34 | <0.0001 | |
| Northern Trust | $204,309.00 | 0.18 | 133,535 | +45.5% | +$63,889.88 | <0.0001 | |
| Bridgeway Capital Management | $199,206.00 | 0.17 | 130,200 | -25.85% | -$69,462.00 | <0.01 | |
| NORTHEAST FINANCIAL CONSULTANTS, INC | $142,290.00 | 0.12 | 93,000 | 0% | +$0 | 0.01 | |
| Citadel Advisors LLC | $107,365.00 | 0.09 | 70,173 | +53.09% | +$37,232.66 | <0.0001 | |
| Marshall Wace | $104,749.00 | 0.09 | 68,463 | New | +$104,749.00 | <0.0001 | |
| Synovus | $81,199.00 | 0.07 | 53,071 | 0% | +$0 | <0.01 | |
| CAPTRUST | $76,500.00 | 0.07 | 50,000 | 0% | +$0 | <0.0001 | |
| Banque Cantonale Vaudoise | $61,000.00 | 0.05 | 40,000 | 0% | +$0 | <0.01 | |
| Stifel | $59,737.00 | 0.05 | 39,044 | +14.69% | +$7,649.96 | <0.0001 | |
| International Assets Investment Management Llc | $56,880.00 | 0.05 | 36,000 | New | +$56,880.00 | <0.0001 | |
| Y Intercept Hong Kong Ltd | $52,204.00 | 0.05 | 34,120 | New | +$52,204.00 | <0.01 | |
| SG Americas Securities, LLC | $49,000.00 | 0.04 | 32,270 | New | +$49,000.00 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $38,874.00 | 0.03 | 25,408 | New | +$38,874.00 | <0.0001 | |
| GOLDEN CAPITAL MANAGEMENT LLC | $38,250.00 | 0.03 | 25,000 | New | +$38,250.00 | <0.01 | |
| Credit Suisse | $38,250.00 | 0.03 | 25,000 | New | +$38,250.00 | <0.0001 | |
| Cubist Systematic Strategies | $37,592.00 | 0.03 | 24,570 | New | +$37,592.00 | <0.0001 | |
| TWO SIGMA SECURITIES LLC | $33,671.00 | 0.03 | 22,007 | New | +$33,671.00 | <0.01 | |
| Charles Schwab | $30,930.00 | 0.03 | 20,216 | 0% | +$0 | <0.0001 | |
| Prudential Financial | $30,906.00 | 0.03 | 20,200 | New | +$30,906.00 | <0.0001 | |
| Xtx Topco Ltd | $30,530.00 | 0.03 | 19,954 | +4.1% | +$1,202.60 | <0.01 | |
| Mariner Llc | $28,994.00 | 0.03 | 18,950 | 0% | +$0 | <0.0001 | |
| Stratos Wealth Advisors LLC | $21,420.00 | 0.02 | 14,000 | 0% | +$0 | <0.01 | |
| Cambridge Investment Research Advisors Inc | $17,000.00 | 0.02 | 11,000 | +4.76% | +$772.73 | <0.0001 | |
| JPMorgan Chase | $16,195.00 | 0.01 | 10,585 | +229.85% | +$11,285.25 | <0.0001 | |
| Tower Research Capital | $12,082.00 | 0.01 | 7,897 | -43.64% | -$9,355.63 | <0.0001 | |
| UBS | $11,747.00 | 0.01 | 7,678 | New | +$11,747.00 | <0.0001 | |
| Bank of America | $8,641.00 | 0.01 | 5,648 | +401.6% | +$6,918.31 | <0.0001 | |
| PNC Financial Services | $8,547.00 | 0.01 | 5,586 | 0% | +$0 | <0.0001 | |
| Simplex Trading Llc | $8,000.00 | 0.01 | 5,329 | -53.62% | -$9,249.01 | <0.0001 | |
| Qube Research & Technologies | $8,268.00 | 0.01 | 5,404 | +135,000% | +$8,261.88 | <0.0001 | |
| Advisor Group Holdings Inc | $2,754.00 | <0.01 | 1,800 | +80% | +$1,224.00 | <0.0001 | |
| Householder Group Estate Retirement Specialist Llc | $589.00 | <0.01 | 385 | 0% | +$0 | <0.0001 | |
| Cibc Private Wealth Group Llc | $1,738.00 | <0.01 | 1,100 | New | +$1,738.00 | <0.0001 | |
| Wells Fargo | $854.00 | <0.01 | 558 | +20% | +$142.33 | <0.0001 | |
| RhumbLine Advisers | $1,670.00 | <0.01 | 1,092 | 0% | +$0 | <0.0001 | |
| Creative Financial Designs Inc Adv | $153.00 | <0.01 | 100 | 0% | +$0 | <0.0001 |